SCHEMBL28613140

SCHEMBL28613140

CC(CCl)CS(=O)(=O)N[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PTGES2 Q9H7Z7 1/20 0.32
▸ NR3C2 P08235 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28628662 0.84 RAB9A (0.34) PTGES2
SCHEMBL22266023 0.77 ALDH1A1 (0.33) NR3C2
SCHEMBL22266027 0.72 KEAP1 (0.41) NR3C2
SCHEMBL25014616 0.71 KCNN4 (0.37) —
SCHEMBL21962888 0.69 GAA (0.38) —
SCHEMBL22265966 0.69 ALDH1A1 (0.32) —
SCHEMBL21962953 0.69 LMNA (0.41) —
SCHEMBL21962948 0.67 LMNA (0.39) —
SCHEMBL21962605 0.66 NR1I2 (0.39) NR3C2
SCHEMBL22280117 0.65 KMT2A (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113316566-A Compounds and compositions for treating conditions associated with NLRP activity 诺华股份有限公司 2021-08-27 — — CN disclosed
Send feedback